East Africa News Post

Complete News World

The Centers for Disease Control and Prevention (CDC) consultants recommend the use of the vaccine

The Centers for Disease Control and Prevention (CDC) consultants recommend the use of the vaccine

(CNN) — Vaccine consultants at the Centers for Disease Control and Prevention (CDC) voted Friday to resume use of Johnson & Johnson’s coronavirus vaccine. The decision was taken after Prof. urgent meeting Where the vaccine-related blood clots were treated.

ACIP members agreed that the benefits of the vaccine outweigh the risks Blood clots A rare vaccine.

Johnson & Johnson vaccine: These are symptoms of a rare case of thrombosis 1:24

According to the words used during the vote: “The Janssen Covid-19 vaccine is recommended for people 18 years of age or older in the United States population under an emergency use license from the FDA.”

“They voted 10 in favor, four against, and one abstaining. “The proposal is successful,” said Dr. Jose Romero, Arkansas Secretary of Health and President of ACIP.

The U.S. Food and Drug Administration (FDA) will update the vaccine label, stating that women under the age of 50 should be aware of the risk of developing blood clots due to the vaccine. Previously, he was responsible for Johnson & Johnson She told ACIP that the company has agreed to review language on its vaccine label, which warns of the risk of blood clots developing. Dr. Joanne Waldstretcher, chief medical officer for the drug company, also indicated that Johnson & Johnson had written a text for the label, which has been reviewed by the Food and Drug Administration. In this text, the company acknowledged that the blood clots association with its label was “reliable”.

READ  The trick Jeff Bezos used to make Amazon succeed in its early years

Dr. Amanda Cohn, Executive Secretary of ACIP, said at the meeting that the Director of the CDC, Dr.

“We are waiting and expecting that the Food and Drug Administration will issue a new language for emergency use authorization,” Cohn said.

Johnson & Johnson vaccine: These are symptoms of a rare case of thrombosis

ACIP has come together to issue updated recommendations about vaccine use and its relationship to the rare blood clotting syndrome which they call thrombosis with thrombocytopenia syndrome (TTS).

Other groups have called it vaccine-induced immune thrombocytopenia, or VITT, but ACIP adheres to a more neutral jargon that doesn’t assume vaccines are causing the condition.

It is characterized by a rare type of blood clots in the brain, and possibly other large blood clots, along with a low number of blood clotting cells called platelets. Some blood specialists said they believed it was caused by an unusual immune reaction that attacks platelets, causing them to clot together.

The cases of six women who suffered from TTS, including one woman who died, led the CDC and the Food and Drug Administration to recommend stopping vaccination in mid-April. Previously, the ACIP said they need more time and more information Before deciding whether to change the vaccine recommendations and how to change them.

With info from Maggie Fox, Lauren Mascarenhas, and Elizabeth Cohen, all from CNN.